Abstract:BACKGROUND: In a randomized trial, the early introduction of peanuts in infants at high risk for allergy was shown to prevent peanut allergy. In this follow-up study, we investigated whether the rate of peanut allergy remained low after 12 months of peanut avoidance among participants who had consumed peanuts during the primary trial (peanut-consumption group), as compared with those who had avoided peanuts (peanut-avoidance group).METHODS: At the end of the primary trial, we instructed all the participants to avoid peanuts for 12 months. The primary outcome was the percentage of participants with peanut allergy at the end of the 12-month period, when the participants were 72 months of age.RESULTS: We enrolled 556 of 628 eligible participants (88.5%) from the primary trial; 550 participants (98.9%) had complete primary-outcome data. The rate of adherence to avoidance in the follow-up study was high (90.4% in the peanut-avoidance group and 69.3% in the peanut-consumption group). Peanut allergy at 72 months was significantly more prevalent among participants in the peanut-avoidance group than among those in the peanut-consumption group (18.6% [52 of 280 participants] vs. 4.8% [13 of 270], P<0.001). Three new cases of allergy developed in each group, but after 12 months of avoidance there was no significant increase in the prevalence of allergy among participants in the consumption group (3.6% [10 of 274 participants] at 60 months and 4.8% [13 of 270] at 72 months, P=0.25). Fewer participants in the peanut-consumption group than in the peanut-avoidance group had high levels of Ara h2 (a component of peanut protein)-specific IgE and peanut-specific IgE; in addition, participants in the peanut-consumption group continued to have a higher level of peanut-specific IgG4 and a higher peanut-specific IgG4:IgE ratio.CONCLUSIONS: Among children at high risk for allergy in whom peanuts had been introduced in the first year of life and continued until 5 years of age, a 12-month period of peanut avoidance was not associated with an increase in the prevalence of peanut allergy. Longer-term effects are not known. (Funded by the National Institute of Allergy and Infectious Diseases and others; LEAP-On ClinicalTrials.gov number, NCT01366846.).

Early Peanut Introduction Awareness, Beliefs, and Practices Among Parents and Caregivers

Early Peanut Introduction in Primary Care: Evaluation of a Multicomponent Intervention

Rates of New Peanut Allergy and Discontinuation Following Introduction in High-Risk Infants

Early Introduction of Food Allergens and Risk of Developing Food Allergy

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

Impact of peanut consumption in the LEAP Study: Feasibility, growth, and nutrition

Development of an innovative curriculum for paediatricians on peanut allergy prevention: How do we address current guidelines?

Successful introduction of peanut in sensitized infants with reported reactions at home

Design of the Intervention to Reduce Early Peanut Allergy in Children (iREACH): A practice‐based clinical trial

Assessing the Effect of Infant Peanut Exposure Guidelines on Peanut Aspiration Using Google Trends Search Analysis

Effect of Avoidance on Peanut Allergy after Early Peanut Consumption

Learning early about peanut-triggered food protein-induced enterocolitis syndrome

Parent-reported offering of allergen foods to infants during complementary feeding: An observational study of New Zealand infants

Early Introduction of Novel and Less-Studied Food Allergens in the Plant-Based Era: Considerations for US and EU Infant Formula Regulations

Feasibility and Safety of the Early Introduction of Allergenic Foods in Asian Infants with Eczema

Safety and adherence of early oral immunotherapy for peanut allergy in a primary care setting: a retrospective cross-sectional study

The Ingestion Question: Public Knowledge of Safe Food Introduction in Children

Risk subgroups and intervention effects among infants at high risk for peanut allergy: A model for clinical decision making

Prevalence and Characteristics of Accidental Ingestions Among Pediatric Food Allergy Patients

Are Peanut Allergies a Concern for Using Peanut-Based Formulated Foods in Developing Countries?

Health Promotion of Early and Sustained Allergenic Food Introduction for the Prevention of Food Allergy